Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

Gonzalez-Ferrer S, Shaw B, Fung L, Landovitz RJ, Uslan DZ, Yang S. Emergence of a novel genotype of extensively drug-resistant Shigella sonnei carrying blaDHA-1 in diverse patient populations, Los[...]

Fillinger RJ, Mishra A, Loza L, Sircaik S, Carriel CC, Mackey AI, Stratton TD, Filler SG, Selmecki AM, Bennett RJ, Anderson MZ. Parasex generates highly[...]

Sullivan K, Chatani-Gada M, Lievense B, Slack C, Abrams E, Bunge K, Stranix-Chibanda L, Crawley FP, Das M, Joseph Davey D, Ghazaryan L, Hattas Y,[...]